Epidemiological studies assessing the relationship between dietary vitamin B2 and the risk of breast cancer have produced inconsistent results. Thus, we conducted this meta-analysis of epidemiologic studies to evaluate this association.
We searched English-language MEDLINE publications and conducted a manual search to screen eligible articles. A random-effect model was used to pool study-specific risk estimates. Egger’s linear regression test was also used to detect publication bias in meta-analysis.
In our meta-analysis, ten studies comprising totally 12,268 breast cancer patients were available in the analyses. Pooled relative risk (RR) comparing the highest to the lowest vitamin B2 intake and breast cancer incidence was 0.85 [95% confidence interval (CI) = 0.76–0.95]. No significant heterogeneity existed across the studies (P = 0.086, I 2 = 40.7%). No publication bias was found. The results of dose–response analysis also showed that an increment of 1 mg/day was inversely related to the risk of breast cancer (RR = 0.94; 95% CI = 0.90–0.99).
Results from our meta-analysis indicated that dietary vitamin B2 intake is weakly related to the reduced risk of breast cancer. Additional research is also necessary to further explore this association.
This is a preview of subscription content,to check access.
Access this article
Similar content being viewed by others
Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A (2015) Global cancer statistics, 2012. CA Cancer J Clin 65(2):87–108
Hulka BS, Moorman PG (2008) Breast cancer: hormones and other risk factors. Maturitas 61(1–2):203–213
Narod SA (2011) Hormone replacement therapy and the risk of breast cancer. Nat Rev Clin Oncol 8(11):669–676
Xue F, Michels KB (2007) Intrauterine factors and risk of breast cancer: a systematic review and meta-analysis of current evidence. Lancet Oncol 8(12):1088–1100
Tirona MT, Sehgal R, Ballester O (2010) Prevention of breast cancer (part I): epidemiology, risk factors, and risk assessment tools. Cancer Investig 28(7):743–750
Stevens VL, McCullough ML, Pavluck AL, Talbot JT, Feigelson HS et al (2007) Association of polymorphisms in one-carbon metabolism genes and postmenopausal breast cancer incidence. Cancer Epidemiol Biomark Prev 16(6):1140–1147
Kim YI (2004) Folate and DNA methylation: a mechanistic link between folate deficiency and colorectal cancer? Cancer Epidemiol Biomark Prev 13(4):511–519
Zhang YF, Shi WW, Gao HF, Zhou L, Hou AJ, Zhou YH (2014) Folate intake and the risk of breast cancer: a dose-response meta-analysis of prospective studies. PLoS One 9(6):e100044
Larsson SC, Giovannucci E, Wolk A (2007) Folate and risk of breast cancer: a meta-analysis. J Natl Cancer Inst 99(1):64–76
Liu Y, Yu QY, Zhu ZL, Tang PY, Li K (2015) Vitamin B2 intake and the risk of colorectal cancer: a meta-analysis of observational studies. Asian Pac J Cancer Prev 16(3):909–913
Moher D, Liberati A, Tetzlaff J, Altman DG (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med 51(4):264–269 (W264)
Wells GA, Shea B, O’Connell D, Peterson J, Welch V, Losos M et al (2012) The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp. Accessed 26 Mar 2016
DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7(3):177–188
Greenland S, Longnecker MP (1992) Methods for trend estimation from summarized dose-response data, with applications to meta-analysis. Am J Epidemiol 135(11):1301–1309
Orsini N, Bellocco R, Greenland S (2006) Generalized least squares for trend estimation of summarized doseresponse data. Stata J 6:40–57
Higgins JPT, Thompson SG (2002) Quantifying heterogeneity in a meta-analysis. Stat Med 21(11):1539–1558
Egger M, Davey Smith G, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315(7109):629–634
Cho E, Holmes M, Hankinson SE, Willett WC (2007) Nutrients involved in one-carbon metabolism and risk of breast cancer among premenopausal women. Cancer Epidemiol Biomark Prev 16(12):2787–2790
Xu X, Gammon MD, Wetmur JG, Bradshaw PT, Teitelbaum SL, Neugut AI et al (2008) B-vitamin intake, one-carbon metabolism, and survival in a population-based study of women with breast cancer. Cancer Epidemiol Biomark Prev 17(8):2109–2116
Dorjgochoo T, Shrubsole MJ, Shu XO, Lu W, Ruan Z, Zheng Y et al (2008) Vitamin supplement use and risk for breast cancer: the Shanghai Breast Cancer Study. Breast Cancer Res Treat 111(2):269–278
Stevens VL, McCullough ML, Sun J, Gapstur SM (2010) Folate and other one-carbon metabolism—related nutrients and risk of postmenopausal breast cancer in the Cancer Prevention Study II Nutrition Cohort. Am J Clin Nutr 91(6):1708–1715
Maruti SS, Ulrich CM, Jupe ER, White E (2009) MTHFR C677T and postmenopausal breast cancer risk by intakes of one-carbon metabolism nutrients: a nested case-control study. Breast Cancer Res 11(6):R91
Negri E, La Vecchia C, Franceschi S, D’Avanzo B, Talamini R, Parpinel M et al (1996) Intake of selected micronutrients and the risk of breast cancer. Int J Cancer 65(2):140–144
Levi F, Pasche C, Lucchini F, La Vecchia C (2001) Dietary intake of selected micronutrients and breast-cancer risk. Int J Cancer 91(2):260–263
Chen J, Gammon MD, Chan W, Palomeque C, Wetmur JG, Kabat GC et al (2005) One-carbon metabolism, MTHFR polymorphisms, and risk of breast cancer. Cancer Res 65(4):1606–1614
Kabat GC, Miller AB, Jain M, Rohan TE (2008) Dietary intake of selected B vitamins in relation to risk of major cancers in women. Br J Cancer 99(5):816–821
Ma E, Iwasaki M, Kobayashi M, Kasuga Y, Yokoyama S, Onuma H et al (2009) Dietary intake of folate, vitamin B2, vitamin B6, vitamin B12, genetic polymorphism of related enzymes, and risk of breast cancer: a case–control study in japan. Nutr Cancer 61(4):447–456
Maruti SS, Ulrich CM, White E (2009) Folate and one-carbon metabolism nutrients from supplements and diet in relation to breast cancer risk. Am J Clin Nutr 89(2):624–633
Shrubsole MJ, Shu XO, Li HL, Cai H, Yang G, Gao YT et al (2011) Dietary B vitamin and methionine intakes and breast cancer risk among Chinese women. Am J Epidemiol 173(10):1171–1182
Bassett JK, Baglietto L, Hodge AM, Severi G, Hopper JL, English DR et al (2013) Dietary intake of B vitamins and methionine and breast cancer risk. Cancer Causes Control 24(8):1555–1563
Yang D, Baumgartner RN, Slattery ML, Wang C, Giuliano AR, Murtaugh MA et al (2013) Dietary intake of folate, B-vitamins and methionine and breast cancer risk among hispanic and non-hispanic white women. PLoS One 8(2):e54495
Cancarini I, Krogh V, Agnoli C, Grioni S, Matullo G, Pala V et al (2015) Micronutrients involved in one-carbon metabolism and risk of breast cancer subtypes. PLoS One 10(9):e0138318
Rivlin RS (1970) Riboflavin metabolism. N Engl J Med 283:463–472
Powers HJ (2003) Riboflavin (vitamin B-2) and health. Am J Clin Nutr 77(6):1352–1360
Conflict of interest
Author Lanting Yu declares that he/she has no conflict of interest. Author Yuyan Tan Lin Zhu declares that he/she has no conflict of interest. Author Lin Zhu declares that he/she has no conflict of interest.
This article does not contain any studies with human participants or animals performed by any of the authors.
About this article
Cite this article
Yu, L., Tan, Y. & Zhu, L. Dietary vitamin B2 intake and breast cancer risk: a systematic review and meta-analysis. Arch Gynecol Obstet 295, 721–729 (2017). https://doi.org/10.1007/s00404-016-4278-4